Figure 1From: Endogenous plasma activated protein C levels and the effect of enoxaparin and drotrecogin alfa (activated) on markers of coagulation activation and fibrinolysis in pulmonary embolismAPC activity at 0, 4, 8 and 12 hours (end of study drug infusion). Course of APC activity at inclusion, after 4 hours, 8 hours and after 12 hours (end of the study drug infusion). Patients receiving placebo as the study drug infusion displayed low APC activity levels. DAA infusion results in a dose-dependent increase in APC activity levels.Back to article page